CFDE Workbench
Information PortalData PortalKnowledge Portal
Search
Graph
Enrichment
Cross
Assistant
Data Matrix
Use Cases
Tools & Workflows
Submit
Documentation
CFDE Workbench

Embolism (Disease Or Phenotype)

Nci:C26759
Msh:D004617
Medcin:MEDCIN:357282
Mdr:MDR:10061169
Id:6cde6c80-409f-5a21-a50f-e928d2607a63
Icpc2icd10eng:MTHU025290
Chv:CHV:4373
Results found

Linked to

 

Label

Description

 

Knowledge Graph Assertion

Rivaroxaban indication Embolism

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Edoxaban indication Embolism

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Rivaroxaban indication Embolism

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Edoxaban indication Embolism

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2025
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2025
    This repository is under review for potential modification in compliance with Administration directives.